Cibus (CBUS) Q2 2026 Earnings Call Transcript
Gene-editing biotech targets $200M+ rice royalty opportunity with cash runway into 2027.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.
More in Finance & Markets
Dow Jones Industrial Average repays the Treasury's rally with interest
Wednesday bought the bond market one session of calm and the Dow Jones Industrial Average spent Thursday paying for it with interest.
Here's Why Sept. 11 Is a Huge Day for the 2027 Social Security COLA
Key PointsThe latest Social Security COLA estimate from Senior Citizens League is 3.6%, down from 3.8% a month ago.
Intellicheck (IDN) Q2 2026 Earnings Call Transcript
Revenue grew 16% year-over-year despite major customer transition risks.
Sensus (SRTS) Q2 2026 Earnings Call Transcript
Financing delays crushed Q2 revenue, but management expects recovery in Q3.
ImmuCell (ICCC) Q2 2026 Earnings Call Transcript
Product sales hit $7.2 million as market share climbed to 19% amid capacity expansion plans.